[ITCI] YoY Quarter Result on 31-Dec-2019 [#Q4]

Stock
[ITCI] Intra-Cellular Therapies, Inc.
Announcement Date
02-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- -16.41%
YoY- 0.40%
Quarter Report
ITCI's Result
ITCI's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 87,433 25,516 12,404 61 0 5 98 210.11%
PBT -44,026 -85,734 -60,689 -40,583 -40,748 -31,267 -27,252 8.31%
Tax -6,772 -541 10 -1,125 5,266 -1,058 233 -
NP -37,254 -85,734 -60,699 -40,583 -40,748 -30,209 -27,485 5.19%
Tax Rate - - - - - - - -
Total Cost 124,687 111,250 73,103 40,643 40,748 30,214 27,583 28.57%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -42.61 -336.00 -489.36 -66,954.04 0.00 -597,600.63 -28,076.04 -66.08%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -0.39 -1.05 -0.76 -0.73 -0.74 -0.56 -0.64 -7.92%
EPS Diluted -0.39 -1.05 -0.76 -0.73 -0.74 -0.56 -0.64 -7.92%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.